Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study to uncover hidden links in stroke recovery

NCT ID NCT07652710

Knowledge-focused Sponsor: Baskent University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will look at how balance, arm movement, and body awareness are related in 53 people who had a stroke at least 6 months ago. Participants will complete tests like standing on a special platform, reaching tasks, and questionnaires. The goal is to understand these connections better so that future rehab can be more personalized and effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help design better, more personalized rehabilitation programs for people recovering from stroke.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new therapy, and the findings may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 53 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals with chronic stroke who are receiving outpatient follow-up and rehabilitation services at the Department of Physical Medicine and Rehabilitation, Baskent University Hospital.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals who experienced a cerebrovascular event at least 6 months previously * Individuals between 18 and 75 years of age * Individuals who have experienced stroke for the first time * Individuals with shoulder, elbow, wrist, and finger muscle tone graded as 2 or 3 according to the Modified Ashworth Scale (MAS) * Individuals scoring 24 points or higher on the Standardized Mini Mental State Examination * Individuals with at least 120° of shoulder range of motion * Individuals who are able to walk independently or with a walking aid Exclusion Criteria: * Presence of communication problems such as difficulties in reading, writing, or speaking * Botulinum toxin injection within the last 3 months * Presence of hemispatial neglect syndrome * Presence of ataxia due to posterior circulation ischemia * Bilateral involvement (bilateral hemiparesis) * Having received physiotherapy within the last 6 months * Presence of orthopedic problems such as shoulder subluxation, shoulder pain, contracture of the hand and wrist * History of upper extremity or thoracic surgery * Presence of stroke-related visual impairments (hemianopia) * Presence of color blindness * Use of antiepileptic medication * History of convulsions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic stroke patient are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic stroke patient

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Baskent University Hospital

    Ankara, Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.